Vir Biotechnology Grants Norgine Exclusive License for Chronic Hepatitis Delta Treatment Candidate

Tuesday, Dec 16, 2025 4:34 pm ET1min read

Texas Community Bancshares, Inc. has announced a new stock repurchase program, authorizing the repurchase of up to 144,364 shares, or approximately 5% of its outstanding common stock. The company has also completed the repurchase of 153,083 shares under a previous program. The repurchases will be made through open market purchases or privately negotiated transactions, subject to market conditions and other factors. The program may be suspended or discontinued at any time.

Vir Biotechnology Grants Norgine Exclusive License for Chronic Hepatitis Delta Treatment Candidate

Comments



Add a public comment...
No comments

No comments yet